$17.92
-1.39 (-7.20%)
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Price Target
Analyst Price Target
+460.8% upside
Low Target
$77.00
Average Target
$100.50
High Target
$121.27
Current Price
$17.92
Current
$17.92
$17.92
Target
$100.50
$100.50
$77.00
$100.50 avg
$121.27
Scenario Analysis
Bear Case
$77.00
329.7%
Low target
Base Case
$100.50
+460.8%
Avg target
Bull Case
$121.27
+576.7%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$31.74
-43.5% from high
52-Week Low
$17.43
+2.8% from low
50-Day SMA
$24.26
-26.1% vs SMA
200-Day SMA
$24.62
-27.2% vs SMA
RSI (14)
35.3
Neutral
Target vs 52W High
$100.50
+216.7% vs high
Next Earnings Report
Nov 10, 2026 · After Market Close
3d
until earnings
EPS Est: $-0.91
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -10.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +116.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.2% |
| MRNA | Hold | 31 | 35% | $149.45 | -38.1% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -60.7% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -35.8% |